Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Jagsonpal Pharma rallies 14% on acquisition update; time to book profit?
Jagsonpal Pharmaceuticals has entered into a definitive agreement to acquire an 85 per cent equity stake in Aequitas Healthcare
Jagsonpal Pharma soars after inking pact to acquire majority stake in Aequitas
Jagsonpal Pharmaceuticals surged 9.79% to Rs 253.90 after the company entered into a definitive Agreement to acquire an 85% equity stake in Aequitas Healthcare (Aequitas), marking its entry into hospital segment.
Motilal Oswal sector of the week: Healthcare; Max, Global Health top picks
Indian healthcare sector remains well positioned for sustained long-term growth, supported by structural demand, expanding hospital infra, higher healthcare spends, and favourable demographic trends.
JioBlackRock enters SIF, launches its first regular-plan product
JioBlackRock enters the SIF segment with a hybrid long-short fund, while ICICI Prudential MF launches a multi-asset active FoF for diversified investing
Jagsonpal Pharmaceuticals to acquire 85% stake in Aequitas Healthcare for ₹21 crore
Shares of Jagsonpal Pharmaceuticals Ltd ended at ₹230.80, down by ₹8.05, or 3.61%, on the BSE.
Vodafone Idea shares end with gains of over 2% after an upmove in the last hour of trade; Here's why
Vodafone Idea shares are likely to see flows worth $25 million for 164.3 million shares in the Nifty 200 Momentum 30 index, $5 million or 33.9 million shares in the Nifty 500 Momentum 50 Index.
Bajaj Healthcare surges after secures SEC recommendation for Cenobamate tablets
Bajaj Healthcare soared 12.98% to Rs 345 after the company said that Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO) has recommended for grant of approval for manufacturing and marketing of Cenobamate Tablets.
Fluence deal signals Honasa’s pivot towards health-beauty convergence
As beauty consumers increasingly demand science-backed and holistic solutions, Honasa is blurring the lines between cosmetics, wellness and healthcare, with nutraceuticals emerging as a new battleground for growth and differentiation.
Nifty indices rejig goes live today: Which stocks will see biggest inflows and outflows?
The NSE’s quarterly index rebalancing takes effect today, triggering significant passive fund flows across Indian equities due to changes in free-float weights. While the Nifty 50 sees limited adjustments, broader strategic indices are witnessing sharper reshuffling.
Omaxe Ltd leads gainers in 'B' group
Bajaj Healthcare Ltd, Prakash Pipes Ltd, Gujarat Natural Resources Ltd and Krishival Foods Ltd Partly Paidup are among the other gainers in the BSE's 'B' group today, 29 June 2026.
Stock Alert: Aurobindo Pharma, Likhitha Infra, Vikran Engineering, Ashoka Buildcon, Bajaj Healthcare
Aurobindo Pharma announced that the United States Food and Drug Administration (USFDA) had completed an inspection at its wholly owned subsidiary, Auroactive Pharma, located in Andhra Pradesh.
Nifty in consolidation mode; can target 24,500-24,600 this week: Angel One
Nifty's 100-DEMA around 24,140-24,170 zone is an immediate hurdle; breakout above this can trigger a rally towards 24,500-24,600 levels, says Osho Krishan, technical and derivatives at Angel One.